The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is set to release the much-anticipated European Drug Report 2023 on the 16th of June. As the leading authority on illicit drugs in the European Union, the EMCDDA’s annual report promises to shed light on the latest trends and developments in the drug situation in Europe​.

European Drug Report 2023 to be released on 16 June

The Launch Event

EMCDDA: They will launch the European Drug Report 2023 at a press conference in Brussels.The event details are as follows:

  • Date: 16 June 2023 at 12.00 (Lisbon), 13.00 CET (Brussels)
  • Venue: European Commission, Berlaymont, VIP corner
  • The event will be live streamed on Europe by Satellite​.

The Speakers

The event will feature keynote speeches from:

  1. Ylva Johansson, European Commissioner for Home Affairs
  2. Alexis Goosdeel, EMCDDA Director​​.

Regrettably, my search for more detailed information on the report’s content and keywords related to ‘EMCDDA’ encountered some obstacles due to difficulties in accessing certain web pages. Nevertheless, I will persist in my search efforts and will update the article with more information as it becomes available.

WHO IS EMCDDA

The EMCDDA is the leading authority on illicit drugs in the European Union and is the reference point on drugs and drug addiction information in Europe.

The EMCDDA releases an annual European Drug Report, which explores the latest trends in drug use and its impact across Europe. The report covers a wide range of topics, including the number of new drugs detected in Europe over the last year, the latest trends in drug production and trafficking, and the substances causing the most concern today​1​.

I also found some key facts about the drug situation in Europe as reported by the EMCDDA:

  • Cannabis remains the most commonly used illicit substance in Europe, while cocaine use continues to rise.
  • Certain countries traditionally reported seizures of methamphetamine, but now reports are coming from across Europe.
  • The report also highlights the impact of social and health inequalities on drug use and harms, which can be significant in many countries and cities.
  • The document also discusses the COVID-19 pandemic’s influence on drug markets, users, services, and harm reduction measures.

DRUG ENFORCEMENT CENTRE